Degree in Chemistry from the State University of Rio de Janeiro, a master's, and doctorate in Chemistry in Nuclear Magnetic Resonance (Military Institute of Engineering), and post-doctorate from the Institute of Medical Biochemistry at UFRJ working with protein NMR. Senior Internship at the University of California, Riverside, in metabolomics. Director of the Natural Products Research Institute (IPPN) from 2018 to 2022. Currently I am Associate Professor at UFRJ, CNPq research and permanent professor in the two graduate programs: Natural Products Chemistry (IPPN-UFRJ) and Pharmacology and Medicinal Chemistry at the Institute of Biomedical Sciences (ICB) at UFRJ. I am also a member of the Drug Development Research Program (ICB-UFRJ). I was responsible for setting up the NMR facility at IPPN-UFRJ in 2010, where I am still the coordinator.
My research is based on the application of Nuclear Magnetic Resonance for the identification of enzyme inhibitors. NMR is used in the screening of molecular fragment libraries and in the analysis of natural products for the identification, quantification, and structural determination of natural products in crude extracts with enzymatic activity.
Ongoing projects aim to find inhibitors for the nucleoside hydrolase and ornithine decarboxylase enzymes as targets for leishmaniasis and for the human AAK1 kinase involved in neurodegenerative diseases and viral infections.
Degree in Chemistry from the State University of Rio de Janeiro, a master's, and doctorate in Chemistry in Nuclear Magnetic Resonance (Military Institute of Engineering), and post-doctorate from the Institute of Medical Biochemistry at UFRJ working with protein NMR. Senior Internship at the University of California, Riverside, in metabolomics. Director of the Natural Products Research Institute (IPPN) from 2018 to 2022. Currently I am Associate Professor at UFRJ, CNPq research and permanent professor in the two graduate programs: Natural Products Chemistry (IPPN-UFRJ) and Pharmacology and Medicinal Chemistry at the Institute of Biomedical Sciences (ICB) at UFRJ. I am also a member of the Drug Development Research Program (ICB-UFRJ). I was responsible for setting up the NMR facility at IPPN-UFRJ in 2010, where I am still the coordinator.
My research is based on the application of Nuclear Magnetic Resonance for the identification of enzyme inhibitors. NMR is used in the screening of molecular fragment libraries and in the analysis of natural products for the identification, quantification, and structural determination of natural products in crude extracts with enzymatic activity.
Ongoing projects aim to find inhibitors for the nucleoside hydrolase and ornithine decarboxylase enzymes as targets for leishmaniasis and for the human AAK1 kinase involved in neurodegenerative diseases and viral infections.